![](/img/cover-not-exists.png)
PCN454 A MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF ELOTUZUMAB/POMALIDOMIDE/DEXAMETHASONE (EPD) VERSUS PANOBINOSTAT/BORTEZOMIB/DEXAMETHASONE (PANO-VD) AND DARATUMUMAB MONOTHERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
Potluri, R., Chen, C., Ranjan, S., Kumar, A., Bhandari, H., Davis, C.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.646
Date:
November, 2019
File:
PDF, 319 KB
2019